Pfizer Covid Vaccines
-
{
- All
- News
-
US Probes Risk Of Stroke From Pfizer Covid Vaccine Booster Dose
Earlier this month, US health officials said they had detected the possible link to ischemic strokes in people over age 65 who received the newer booster shots.
-
3 Covid Shots Generate Good Response In Under-5s: Pfizer-BioNTech
The Pfizer-BioNTech Covid-19 vaccine is safe and effective for children aged six months to under five years when given in 3 doses.
-
New Zealand Links 26-Year-Old Man's Death To Pfizer Covid Vaccine
New Zealand authorities on Monday said they had linked a 26-year-old man's death to Pfizer Inc's COVID-19 vaccine after the person suffered myocarditis, a rare inflammation of the heart muscle, after taking his first dose.
-
Pfizer Covid Vaccine For Children In EU To Be Available In Two Weeks
The EU's main Covid vaccine provider, BioNTech/Pfizer, will have jabs available for children in the bloc in two weeks' time, European Commission chief Ursula von der Leyen said Wednesday.
-
European Union Approves Pfizer Covid Jab For 5 To 11-Year-Olds
The EU's drug regulator approved Pfizer's coronavirus jab for children aged 5 to 11 on Thursday, clearing the way for the vaccination in a cohort where the virus is rapidly spreading.
-
Pfizer Vaccine 100% Effective In Adolescents After 4 Months
Pfizer and BioNTech said Monday their COVID-19 vaccine remained 100 percent effective in children 12 to 15 years old, four months after the second dose.
-
Pfizer's Covid Vaccine Trial Data Shows Long-Term Efficacy In Adolescents
Pfizer Inc said on Monday its COVID-19 vaccine provided strong long-term protection against the virus in a late-stage study conducted among adolescents aged 12 to 15 years.
-
Iraq Gets 1.2 Million Pfizer Covid Vaccine Doses Amid Fears Of 4th Wave
Iraq said Saturday it has received 1.2 million doses of Pfizer-BioNTech's COVID-19 vaccine through the Covax sharing scheme, amid fears of a fourth wave in the country.
-
"Turning Point": Joe Biden On US' Pfizer Vaccine Approval For 5 To 11 Year Olds
The United States can now start giving children aged 5-11 the Pfizer-BioNtech Covid vaccine, US health authorities said Tuesday as they gave final approval to this new phase of fighting the pandemic.
-
Pfizer Says COVID-19 Vaccine More Than 90% Effective In Children Aged 5-11
Pfizer's Covid-19 vaccine is more than 90 percent effective in preventing symptomatic disease among children aged 5-to-11, the company said in a document released Friday that put forward its case for authorization.
-
Pfizer Covid Vaccine Safe For Children Aged 5-11: Clinical Trial Results
Pfizer and BioNTech on Monday said clinical trial results showed their coronavirus vaccine was "safe, well tolerated" and produced a "robust" immune response in children aged five to 11, adding that they would seek regulatory approval shortly.
-
Pfizer Jab Side Effects In 12-15 Year Olds Mild To Moderate: Study
A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate.
-
US Grants Pfizer Covid Vaccine Full Approval
The US Food and Drug Administration on Monday fully approved Pfizer's Covid-19 vaccine for people aged 16 and older, a move expected to trigger a new wave of vaccine mandates as the Delta variant batters the country.
-
Longer 8-Week Gap Between Pfizer Doses Boosts Antibodies, Study Finds
An interval of eight to 10 weeks between doses of the Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE boosts the effectiveness of the two-shot regimen compared with a shorter interval, a U.K. study found.
-
Pfizer In "Final Stages" Of Approval For Covid Vaccine In India: CEO
Pfizer CEO Albert Bourla has said that his company hope to finalise a deal with the Indian government on the approval for the company's Covid vaccine. A few days ago, NITI Aayog member D VK Paul, too, had said the same thing.
-
US Probes Risk Of Stroke From Pfizer Covid Vaccine Booster Dose
Earlier this month, US health officials said they had detected the possible link to ischemic strokes in people over age 65 who received the newer booster shots.
-
3 Covid Shots Generate Good Response In Under-5s: Pfizer-BioNTech
The Pfizer-BioNTech Covid-19 vaccine is safe and effective for children aged six months to under five years when given in 3 doses.
-
New Zealand Links 26-Year-Old Man's Death To Pfizer Covid Vaccine
New Zealand authorities on Monday said they had linked a 26-year-old man's death to Pfizer Inc's COVID-19 vaccine after the person suffered myocarditis, a rare inflammation of the heart muscle, after taking his first dose.
-
Pfizer Covid Vaccine For Children In EU To Be Available In Two Weeks
The EU's main Covid vaccine provider, BioNTech/Pfizer, will have jabs available for children in the bloc in two weeks' time, European Commission chief Ursula von der Leyen said Wednesday.
-
European Union Approves Pfizer Covid Jab For 5 To 11-Year-Olds
The EU's drug regulator approved Pfizer's coronavirus jab for children aged 5 to 11 on Thursday, clearing the way for the vaccination in a cohort where the virus is rapidly spreading.
-
Pfizer Vaccine 100% Effective In Adolescents After 4 Months
Pfizer and BioNTech said Monday their COVID-19 vaccine remained 100 percent effective in children 12 to 15 years old, four months after the second dose.
-
Pfizer's Covid Vaccine Trial Data Shows Long-Term Efficacy In Adolescents
Pfizer Inc said on Monday its COVID-19 vaccine provided strong long-term protection against the virus in a late-stage study conducted among adolescents aged 12 to 15 years.
-
Iraq Gets 1.2 Million Pfizer Covid Vaccine Doses Amid Fears Of 4th Wave
Iraq said Saturday it has received 1.2 million doses of Pfizer-BioNTech's COVID-19 vaccine through the Covax sharing scheme, amid fears of a fourth wave in the country.
-
"Turning Point": Joe Biden On US' Pfizer Vaccine Approval For 5 To 11 Year Olds
The United States can now start giving children aged 5-11 the Pfizer-BioNtech Covid vaccine, US health authorities said Tuesday as they gave final approval to this new phase of fighting the pandemic.
-
Pfizer Says COVID-19 Vaccine More Than 90% Effective In Children Aged 5-11
Pfizer's Covid-19 vaccine is more than 90 percent effective in preventing symptomatic disease among children aged 5-to-11, the company said in a document released Friday that put forward its case for authorization.
-
Pfizer Covid Vaccine Safe For Children Aged 5-11: Clinical Trial Results
Pfizer and BioNTech on Monday said clinical trial results showed their coronavirus vaccine was "safe, well tolerated" and produced a "robust" immune response in children aged five to 11, adding that they would seek regulatory approval shortly.
-
Pfizer Jab Side Effects In 12-15 Year Olds Mild To Moderate: Study
A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate.
-
US Grants Pfizer Covid Vaccine Full Approval
The US Food and Drug Administration on Monday fully approved Pfizer's Covid-19 vaccine for people aged 16 and older, a move expected to trigger a new wave of vaccine mandates as the Delta variant batters the country.
-
Longer 8-Week Gap Between Pfizer Doses Boosts Antibodies, Study Finds
An interval of eight to 10 weeks between doses of the Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE boosts the effectiveness of the two-shot regimen compared with a shorter interval, a U.K. study found.
-
Pfizer In "Final Stages" Of Approval For Covid Vaccine In India: CEO
Pfizer CEO Albert Bourla has said that his company hope to finalise a deal with the Indian government on the approval for the company's Covid vaccine. A few days ago, NITI Aayog member D VK Paul, too, had said the same thing.
